Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal Women

NCT04940026 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Healthy Volunteers

Interventions

DRUG: amcenestrant
DRUG: [14C]-SAR439859 microtracer
DRUG: [14C]-SAR439859

Sponsor

Sanofi